Iranian Journal of Neurology 2017. 16(3):112-117.

Stroke subtypes, risk factors and mortality rate in northwest of Iran
Mehdi Farhoudi, Kaveh Mehrvar, Homayoun Sadeghi-Bazargani, Mazyar Hashemilar, Manouchehr Seyedi-Vafaee, Elyar Sadeghi-Hokmabad, Reza Rikhtegar, Babak Saber-Maroof, Mohammad Abutalebi, Mahsa Rezaei, Sahar Vaferi, Alireza Aghili, Omid Ebrahimi, Alireza Majdi, Mohammad Hasan Mokhtare, Hadiseh Kavandi, Hadi Ahmadi, Ramak Barnous

Abstract


Background: Stroke is the second most common cause of death and first cause of disability in adults in the world. About 80% of all stroke deaths occur in developing countries. So far, the data on stroke epidemiology have been limited in Iran. Therefore, this study was focused on stroke demographic data, risk factors, types and mortality.

Methods: A retrospective study was done in two university tertiary referral hospitals in Tabriz, northwest of Iran, from March 2008 to April 2013. Patients diagnosed with stroke were enrolled in the study. Demographic data, stroke subtypes, duration of hospitalization, stroke risk factors and hospital mortality rate were recorded for all the patients.

Results: A total number of 5355 patients were evaluated in the present study. Mean age of the patients was 67.5 ± 13.8 years, and 50.6% were men. Final diagnosis of ischemic stroke was made in 76.5% of the patients, intra-cerebral hemorrhage (ICH) with or without intra-ventricular hemorrhage (IVH) in 14.3% and subarachnoid hemorrhage (SAH) in 9.2%. Stroke risk factors among the patients were hypertension in 68.8% of the patients, diabetes mellitus (DM) in 23.9%, smoking in 12.6% and ischemic heart diseases (IHD) in 17.1%. Mean hospital stay was 17.3 days. Overall, the in-hospital mortality was 20.5%.

Conclusion: Compared to other studies, duration of hospital stay was longer and mortality rate was higher in this study. Hypertension was the most common risk factor and cardiac risk factors and DM had relatively lower rate in comparison to other studies. Because of insufficient data on the epidemiology, patterns, and risk factors of stroke in Iran, there is a necessity to develop and implement a national registry system.

Keywords


Stroke; Epidemiology; Risk Factors; Iran

Full Text:

PDF

References


Kim JS. Stroke in Asia: A global disaster.Int J Stroke 2014; 9(7): 856-7.

Daneshfard B, Izadi S, Shariat A, Toudaji MA, Beyzavi Z, Niknam L. Epidemiology of stroke in Shiraz, Iran. Iran J Neurol 2015; 14(3): 158-63.

Strong K, Mathers C, Bonita R. Preventing stroke: Saving lives around the world. Lancet Neurol 2007; 6(2): 182-7.

The World Bank. Iran, Islamic Rep. (Graph) [Online]. [cited 2014]; Available from: URL:https://data.worldbank.org/country/iran- islamic-rep

Delbari A, Salman RR, Tabatabaei SS, LokkJ. A stroke study of an urban area of Iran: Risk factors, length of stay, case fatality, and discharge destination. J Stroke Cerebrovasc Dis 2010; 19(2): 104-9.

Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour- Mobarhan M, et al. Excessive incidence of stroke in Iran: Evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 2010; 41(1): e3-e10.

Borhani-Haghighi A, Safari R, HeydariST, Soleimani F, Sharifian M, Yektaparast KS, et al. Hospital mortality associated with stroke in southern Iran. Iran J Med Sci 2013; 38(4): 314-20.

Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran- Systematic and critical review. BMC Neurol 2010; 10: 72.9. Sridharan SE, Unnikrishnan JP, Sukumaran S, Sylaja PN, Nayak SD, Sarma PS, et al. Incidence, types, risk factors, and outcome of stroke in a developing country: The Trivandrum Stroke Registry. Stroke 2009; 40(4):1212-8.

al Rajeh S, Awada A, Niazi G, Larbi E.Stroke in a Saudi Arabian National Guard community. Analysis of 500 consecutive cases from a population-based hospital.Stroke 1993; 24(11): 1635-9.

Ahangar AA, Ashraf Vaghefi SB, Ramaezani M. Epidemiological evaluation of stroke in Babol, northern Iran (2001-2003). Eur Neurol 2005; 54:93-7.

Oveisgharan S, Sarrafzadegan N, Shirani S, Hosseini S, Hasanzadeh P, Khosravi A. Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate.Cerebrovasc Dis 2007; 24(6): 495-9.

Khaw AV, Kessler C. Stroke: Epidemiology, risk factors, and genetics. Hamostaseologie 2006; 26(4): 287-97.

Kamran S, Bener AB, Deleu D, Khoja W, Jumma M, Al Shubali A, et al. The level of awareness of stroke risk factors and symptoms in the Gulf Cooperation Council countries: Gulf Cooperation Council stroke awareness study. Neuroepidemiology 2007; 29(3-4): 235-42.

Oxfordshire project [Online]. [cited 2014] Available from: URL: https://www.oxfordshireproject.co.uk/about-us/16. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: Data from the European BIOMED Stroke Project. Stroke 2003; 34(3): 688-94.

Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, et al. American heart association prevention conference. iv. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997; 28(7): 1507-17.

Soler EP, Ruiz VC. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: Similarities and differences. Curr Cardiol Rev 2010; 6(3):138-49.

Arboix A, Alio J. Cardioembolic stroke: Clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev 2010; 6(3): 150-61.

Lasek-Bal A, Gasior Z. Cardiovascular diseases in patients 65 years and younger with non-cardiogenic stroke. Arch Med Sci 2016; 12(3): 556-62.

Ingall TJ, Homer D, Baker HL Jr, Kottke BA, O'Fallon WM, Whisnant JP. Predictors of intracranial carotid artery atherosclerosis. Duration of cigarettesmoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991; 48(7): 687-91.

Mast H, Thompson JL, Lin IF, Hofmeister C, Hartmann A, Marx P, et al. Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack. Stroke 1998; 29(5): 908-12.

Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: A population-based study of incidence and risk factors.Stroke 1999; 30(12): 2513-6.

al-Rajeh S, Larbi EB, Bademosi O, Awada A, Yousef A, al-Freihi H, et al. Stroke register: Experience from theeastern province of Saudi Arabia. Cerebrovasc Dis 1998; 8(2): 86-9.

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol2009; 8(4): 355-69.

Benamer HT, Grosset D. Stroke in Arab countries: A systematic literature review. J Neurol Sci 2009; 284(1-2): 18-23.

Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, et al. Trends in treatment and outcome of stroke patients in Finland from 1999 to2007. PERFECT Stroke, a nationwide register study. Ann Med 2011; 43(Suppl 1): S22-S30.

Borhani HA, Karimi AA, Amiri A, Ghaffarpasand F. Knowledge and attitude towards stroke risk factors, warning symptoms and treatment in an Iranian population. Med Princ Pract 2010; 19(6):468-72


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.